Ligand Pharmaceuticals (LGND) Shares Issued (2016 - 2025)
Historic Shares Issued for Ligand Pharmaceuticals (LGND) over the last 16 years, with Q2 2025 value amounting to $8.2 million.
- Ligand Pharmaceuticals' Shares Issued fell 1374.58% to $8.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $53.2 million, marking a year-over-year increase of 5298.97%. This contributed to the annual value of $65.6 million for FY2024, which is 19217.75% up from last year.
- As of Q2 2025, Ligand Pharmaceuticals' Shares Issued stood at $8.2 million, which was down 1374.58% from $4.2 million recorded in Q1 2025.
- Ligand Pharmaceuticals' Shares Issued's 5-year high stood at $26.5 million during Q1 2021, with a 5-year trough of $347000.0 in Q1 2022.
- Moreover, its 5-year median value for Shares Issued was $4.3 million (2021), whereas its average is $7.6 million.
- In the last 5 years, Ligand Pharmaceuticals' Shares Issued soared by 619287.41% in 2021 and then plummeted by 9869.02% in 2022.
- Over the past 5 years, Ligand Pharmaceuticals' Shares Issued (Quarter) stood at $4.3 million in 2021, then plummeted by 67.26% to $1.4 million in 2022, then skyrocketed by 365.81% to $6.5 million in 2023, then surged by 196.31% to $19.3 million in 2024, then plummeted by 57.39% to $8.2 million in 2025.
- Its Shares Issued was $8.2 million in Q2 2025, compared to $4.2 million in Q1 2025 and $19.3 million in Q4 2024.